NCT07055386View on ClinicalTrials.gov

A Study to Compare the Efficacy and Safety of GZR102 Injection and GZR18 Injection in Type 2 Diabetes Mellitus

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

June 24, 2025

Primary Completion Date

May 31, 2026

Study Completion Date

January 31, 2027

Conditions
Type 2 Diabetes Mellitus (T2DM)
Interventions
DRUG

GZR102

Administered SC

DRUG

GZR18

Administered SC

Trial Locations (1)

Unknown

Study site 01, Beijing

Sponsors
All Listed Sponsors
lead

Gan & Lee Pharmaceuticals.

INDUSTRY

NCT07055386 - A Study to Compare the Efficacy and Safety of GZR102 Injection and GZR18 Injection in Type 2 Diabetes Mellitus | Biotech Hunter | Biotech Hunter